INTRODUCTION:

Diabetes mellitus is a chronic disease that affects millions of people worldwide. Elevated blood sugar levels caused by the body's inability to produce enough insulin or use it effectively are its defining characteristic. The hormone insulin, which is secreted by the pancreas, is crucial for regulating blood sugar levels and facilitating the uptake of glucose by cells for energy. When insulin isn't functioning correctly, blood glucose levels rise, which can lead to a variety of short-term and long-term health problems.¹

The body has trouble regulating blood sugar (glucose) levels in people with diabetes mellitus (DM), a chronic metabolic condition. Either inadequate insulin synthesis by the pancreas or ineffective insulin use by the body are the main causes of this. The metabolism of proteins, fats, and carbohydrates as well as the maintenance of normal blood sugar levels depend on the hormone insulin.² Hyperglycemia results from elevated blood sugar levels caused by impaired insulin function. If left untreated, diabetes mellitus can cause a number of problems that impact the body's organs and systems. Chronic hyperglycemia can harm the heart, kidneys, eyes, nerves, and blood vessels³.

SYMPTOMS OF DIABETES MELLITUS:

The symptoms of diabetes mellitus can vary depending on the type and severity of the condition, but common signs of the condition include:

· Excessive Thirst (Polydipsia): Dehydration and excessive thirst are brought on by the body losing more water through frequent urination due to high blood sugar levels.

· Frequent Urination (Polyuria): Increased kidney filtration brought on by elevated blood glucose levels results in increased urine production, particularly at night.

· Extreme Hunger (Polyphagia): The body cannot use glucose as it should when insulin resistance or insufficiency occurs, which makes cells feel "starved" and causes extreme hunger.

· Inexplicable Weight Loss: Individuals with uncontrolled diabetes may experience weight loss despite increasing their intake because their body starts using muscle and fat as fuel because it is unable to properly use glucose.

· Fatigue: Even after resting, people with diabetes frequently experience fatigue because glucose isn't used for energy efficiently.

· Hazy Vision: High blood sugar can draw fluid out of tissues, including the eyes, making it difficult to focus and resulting in blurred vision.

· Slow Healing of Cuts or Infections: Diabetes weakens immunity, which makes it more challenging for the body to heal wounds and fend off infections.

· Neuropathy: which can be caused by chronically high blood sugar, is indicated by tingling or numbness in the hands or feet.

· Frequent Infections: People with diabetes are more prone to infections, particularly skin and urinary tract infections, due to high blood sugar and decreased immune function.

· Dry Skin and Itching: Poor circulation and dehydration induced by diabetes can result in dry, itchy skin.^4,5

TYPE OF DIABETES MELLITUS:

Diabetes Mellitus principally includes two primary types: Type 1 and Type 2, while there are other less prevalent kinds.

1. Type 1 Diabetes:

Although it can strike at any age, type 1 diabetes, formerly known as insulin-dependent diabetes or juvenile diabetes, usually presents in childhood or adolescence.⁶ It is an autoimmune disease where the immune system of the body unintentionally targets and kills the beta cells in the pancreas that create insulin. The hormone insulin, which is necessary for managing blood sugar levels, is thus unable to be produced by the body. Insulin pumps or injections are important for persons with Type 1 diabetes to survive.⁷

Symptoms: Increased thirst and urination Unexplained weight loss Extreme hunger Fatigue Blurry vision⁸

Causes: Although the specific aetiology of Type 1 diabetes is still understood, environmental triggers such viral infections and genetic factors are suspected to be involved.⁹

Management: Type 1 diabetes requires lifelong insulin therapy, combined with regular blood sugar testing. Carbohydrate counting, a nutritious diet, and regular physical activity are necessary in maintaining blood glucose levels within a goal range.¹⁰

2. Type 2 Diabetes: The most widespread sort of diabetes, type 2, normally affects adults, but as obesity rates grow, it is also happening in children and adolescents.¹¹ Unlike Type 1, insulin resistance occurs when the body's cells do not respond to insulin as they should. In order to maintain blood sugar levels within normal ranges, the pancreas eventually runs out of insulin.¹² Signs and symptoms Increased urination and thirst Weariness hazy vision Frequent infections or sores that don't heal quickly Hand or foot numbness or tingling¹³

Causes: Obesity, a poor diet, and inactivity are the main lifestyle factors that contribute to type 2 diabetes. Genetics also has a major role in its growth.¹⁴

Management: In the early stages of Type 2 diabetes, lifestyle changes including regular exercise, a healthier diet, and weight loss can often help control the condition. Insulin or medication may be required if blood sugar levels stay high. Blood glucose monitoring and routine medical examinations remain essential.¹⁵

3. Gestational Diabetes: The hallmark of gestational diabetes is elevated blood sugar levels that develop during pregnancy but usually decrease after birth.¹⁶ It occurs when the body cannot produce enough insulin to meet the growing needs of pregnancy. Women who have had gestational diabetes are at a higher risk of developing type 2 diabetes in the future.¹⁷ Signs and symptoms Increased thirst and urination Weariness Despite the fact that gestational diabetes may not always show obvious symptoms, screening is essential during pregnancy.¹⁸

Administration: Treatment for gestational diabetes typically consists of nutrition, exercise, and blood sugar monitoring. In some circumstances, insulin therapy might be required. After giving birth, blood sugar levels usually return to normal, but it's important to have regular postpartum examinations to monitor for Type 2 diabetes.¹⁹

4. Maturity-Onset Diabetes of the Young (MODY): A genetic mutation that affects insulin production causes Maturity-Onset Diabetes of the Young (MODY), an uncommon type of diabetes that usually manifests in adolescence or early adulthood. MODY is typically inherited in an autosomal dominant form, in contrast to Type 1 or Type 2. High blood glucose levels are caused by a malfunction in the pancreas's ability to secrete insulin in people with MODY.²⁰

Symptoms: Like Type 2 diabetes, but usually manifests earlier in life.²¹

Management: Treatment is contingent upon the particular genetic mutation and the patient's reaction to treatment. While some people may manage the problem with diet and exercise, others may need insulin or other drugs²².

5. Latent Autoimmune Diabetes in Adults (LADA): Because it shares characteristics with both Type 1 and Type 2 diabetes, latent autoimmune diabetes in adults (LADA) is also known as Type 1.5 diabetes. It is an autoimmune disease that often strikes adults in their 30s or 40s. LADA develops gradually, and people with LADA frequently don't need insulin at first. However, as their cells that produce insulin deteriorate over time, insulin therapy becomes essential.²³

Symptoms: Like Type 1 diabetes, but with a delayed onset.²⁴

Management: Insulin therapy is used to treat LADA, along with lifestyle modifications like eating a balanced diet and exercising.²⁵

6. Other Specific Types: Other Specific Types: Other, less common types of diabetes can be brought on by drug-induced diabetes (e.g., from certain drugs), pancreatic disorders, or genetic mutations. Depending on the underlying cause, these categories frequently call for particular therapies²⁶.

COMPLICATIONS DIABETES MELLITUS:

Diabetes mellitus, particularly if left untreated, can result in a number of severe and potentially fatal complications.²⁷ These complications are brought on by persistently elevated blood sugar (hyperglycemia), which harms the body's organs and systems. Although those with long-term or poorly managed diabetes are more likely to experience severe problems, those with insufficient diabetic management may also be affected. The main complications of diabetes are listed below²⁸.

1. Cardiovascular Disease: Individuals with diabetes are more vulnerable to peripheral arterial disease, coronary artery disease, heart attacks, and strokes. High blood sugar levels increase the risk of atherosclerosis, or artery constriction, and high blood pressure, which over time can damage blood vessels and the nerves that control the heart and blood vessels. The risk of heart disease and stroke is two to four times higher for diabetics than for those without the disease.²⁸

2. Kidney Damage (Diabetic Nephropathy): Diabetes is the main cause of chronic kidney disease and kidney failure. The kidneys' ability to filter waste from the blood can be hampered by damage to the small blood capillaries caused by high blood sugar. One of the first signs of kidney illness is protein in the urine, which can progress to renal failure if left untreated. In severe cases, dialysis or a kidney transplant may be required.²⁹

3. Nerve Damage (Neuropathy): Diabetic neuropathy, sometimes referred to as nerve damage, is a common side effect of diabetes. High blood sugar most often affects the legs and feet, but it can damage nerves anywhere in the body. Possible symptoms include weakness, tingling, pain, or numbness in the extremities. In severe cases, nerve damage can cause lack of sensation, which makes it difficult for people to identify wounds or diseases. This can lead to foot ulcers and, in extreme cases, amputations.³⁰

4. Eye Problems (Diabetic Retinopathy): Diabetic retinopathy is a disorder in which the blood vessels in the retina are harmed by high blood sugar. If left untreated, this condition can result in blindness. Over time, diabetic retinopathy may progress without causing any symptoms at first. Glaucoma, or elevated intraocular pressure, and cataracts, or clouding of the lens, are other eye conditions associated with diabetes. For early detection, routine eye exams are crucial³¹.

5. Poor Circulation and Infections: Diabetes can cause circulation problems, especially in the limbs. The body's capacity to fight infections and repair wounds might be slowed down by poor circulation. People with diabetes are more likely to get infections, especially in their feet. Serious side effects, such as gangrene, which may necessitate amputations, can result from untreated infections ³².

6. Skin Conditions: Skin infections and other skin-related problems are more common in people with diabetes. Itching, dry skin, and bacterial and fungal infections are common skin issues. Diabetes-related immune system dysfunction and poor blood circulation can raise the chance of developing certain skin disorders. Furthermore, diabetic dermopathy, which results in black, scaly spots on the skin, is more common in patients with diabetes³³.

7. Gum Disease (Periodontal Disease): Diabetes raises the risk of gum disease (also known as periodontal disease) because high blood sugar impairs immunity, making it more difficult to fend off infections. Gum disease can cause bleeding, inflamed gums, and in extreme situations, tooth loss. Gum disease in diabetics can be avoided with regular dental care, which includes brushing, flossing, and examinations³⁴.

8. Hearing Impairment: Due to nerve damage and poor blood circulation, which affects the inner ear, people with diabetes are more prone to suffer from hearing loss. Research indicates that people with diabetes, especially those who have had the disease for a long time, are more likely to experience hearing loss³⁵.

9. Mental Health Problems: Mental health can be significantly impacted by diabetes. Anxiety, depression, and a higher risk of cognitive impairment can result from the physical difficulties of diabetes and the stress of treating the illness. A syndrome known as "diabetes distress," in which the emotional strain of having diabetes results in emotions of powerlessness or frustration, can also affect certain people with the disease³⁶.

10. Gastroparesis: When the stomach takes too long to empty, it can cause gastroparesis, also known as delayed stomach emptying. It is caused by damage to the nerves that affects the ability of the stomach muscles to contract. This can lead to symptoms like bloating, nausea, vomiting, and difficulty regulating blood sugar levels. If gastroparesis hinders proper digestion and absorption of nutrients, blood glucose management may become more challenging.³⁷

11. Sexual Dysfunction: Both men and women with diabetes may experience problems with their sexual health. Diabetes damages blood vessels and nerves, which can lead to erectile dysfunction in males. Diabetes frequently results in decreased blood flow and nerve damage, which can cause vaginal dryness and decreased sexual desire in women³⁸.

RISK FACTORS OF DIABETES MELLITUS:

Diabetes mellitus, especially Type 2 diabetes, is caused by a combination of genetic, environmental, and lifestyle factors. While certain risk factors are beyond an individual's control, many may be managed or changed by changing their lifestyle. Understanding these risk factors can help with early detection and prevention.³⁹

1. Genetics and Family History: You are more likely to develop diabetes if you have a family history of the condition. A close relative with diabetes, such as a parent or sibling, increases the risk of developing the disease. Insulin resistance and the body's capacity to control blood glucose levels are influenced by genetic factors. Type 2 diabetes is also impacted by family history, particularly in those with a history of obesity or cardiovascular illness, even if Type 1 diabetes has a greater hereditary component⁴⁰.

2. Age: People are more likely to get Type 2 diabetes as they get older. Because the body's capacity to use insulin efficiently tends to decline with age, people over 45 are more vulnerable. The risk of diabetes is further increased by weight gain and a more sedentary lifestyle, both of which are prevalent in older persons⁴¹.

3. Obesity and Overweight: Being overweight, especially in the abdomen, is one of the main risk factors for Type 2 diabetes. Obesity aggravates insulin resistance, which causes the body's cells to react improperly to insulin, leading to elevated blood sugar levels. Insulin activity is inhibited by substances produced by adipose tissue, particularly visceral fat (fat around internal organs). Maintaining a healthy weight through diet and exercise is one of the best ways to reduce the risk of diabetes.⁴²

4. Sedentary Lifestyle: One of the main risk factors for Type 2 diabetes is a lack of physical activity. Maintaining a healthy weight and improving insulin utilization are two benefits of regular exercise. Long stretches of sitting or inactivity are examples of sedentary behavior that raises the risk of insulin resistance and obesity, two conditions that are closely related to diabetes⁴³.

5. Poor Diet: Consuming a lot of processed foods, sugar-filled beverages, unhealthy fats, and refined carbs raises the risk of Type 2 diabetes by causing weight gain and insulin resistance. Diabetes is more likely to develop in those who eat diets poor in fruits, vegetables, fiber, and whole grains. Frequent ingestion of foods high in calories but low in nutrients can result in poor blood sugar management and obesity⁴⁴.

6. Ethnicity: Some ethnic groups are more likely than others to have diabetes. People with African, Hispanic, Native American, Asian, and Pacific Islander heritage are more likely than those with European ancestry to have type 2 diabetes. This higher risk could be brought on by a combination of environmental factors, such as nutrition and lifestyle, and genetic predisposition⁴⁵.

7. Hypertension: Hypertension is a common risk factor for Type 2 diabetes. Damage to blood vessels brought on by high blood pressure may affect circulation and insulin use. One of the main contributing factors to the development of diabetes is hypertension, which frequently coexists with insulin resistance. Diabetes risk can be decreased by controlling blood pressure with medication, diet, and exercise⁴⁶.

8. High Lipid and Cholesterol Levels: Another risk factor for Type 2 diabetes is having low HDL (good cholesterol) and high triglyceride levels. People with obesity and insulin resistance frequently have unhealthy cholesterol levels, which raises their chance of acquiring the conditions. Reducing the risk of diabetes requires maintaining appropriate cholesterol levels by food, exercise, and medication⁴⁷.

9. Gestational Diabetes: Pregnant women who have gestational diabetes have a significantly increased risk of developing Type 2 diabetes later in life. Gestational diabetes arises when the body cannot produce enough insulin to meet the increasing demands during pregnancy. Although gestational diabetes usually resolves after delivery, women who have experienced it should continue to monitor their blood sugar levels.⁴⁸

10. Polycystic Ovary Syndrome (PCOS): The hormonal condition known as polycystic ovarian syndrome (PCOS) can cause insulin resistance, which increases the risk of Type 2 diabetes in women who have PCOS. Obesity, irregular menstruation cycles, and high testosterone levels are linked to the illness. It is important to keep an eye out for diabetic symptoms in women with PCOS, especially if they are overweight or obese ⁴⁹.

11. Smoking: It is well known that smoking increases the risk of developing diabetes and other health issues. Smoking raises the risk of Type 2 diabetes by causing inflammation and insulin resistance. Additionally, it raises abdominal fat levels, which raises the risk of diabetes even more. Giving up smoking can enhance general health and lower the risk of diabetes⁵⁰.

12. Stress and Mental Health Problems: Type 2 diabetes may develop as a result of ongoing stress and poor mental health. Emotional eating can result in poor eating habits and weight gain, and stress hormones like cortisol can affect insulin synthesis and function. Diabetes risk can be further increased by depression and anxiety, which can also impair motivation to practice healthy habits like exercise and a balanced diet⁵¹.

PREVENTION AND TREATMENT DIABETES MELLITUS:

Medication, lifestyle changes, and regular monitoring are the three main strategies used to prevent and treat diabetes mellitus. These are some strategies for managing and reducing the

Prevention:

· Healthy Diet: Eating a balanced diet that includes lots of fruits, vegetables, whole grains, and lean proteins while limiting processed and sugary foods can help maintain healthy blood sugar levels⁵³.

· Frequent Exercise: Walking, cycling, swimming, and other forms of regular exercise help the body use insulin more effectively and lower blood sugar levels.⁵⁴

· Weight management: The key to lowering the risk of Type 2 diabetes is maintaining a healthy weight. The risk can be considerably decreased with even a modest weight loss⁵⁵.

· Avoiding Smoking: Smoking increases the risk of developing diabetes and can worsen complications in individuals who already have the condition.⁵⁶

· Limiting Alcohol: Excessive alcohol intake can affect blood sugar levels and contribute to diabetes complications.⁵⁷

· Regular Health Checkups: Monitoring blood glucose levels and getting regular checkups can help catch early signs of diabetes, allowing for early intervention.⁵⁸

Treatment:

Depending on the kind of diabetes a person has, the mainstays of treatment for diabetes mellitus include insulin therapy, medicines, and lifestyle changes. Insulin therapy is crucial for people with Type 1 diabetes since the body is unable to manufacture insulin.⁵⁹ This covers a spectrum of insulin types that can be delivered by injection or insulin pump, including rapid-acting, short-acting, intermediate-acting, and long-acting insulin. Additionally, blood sugar levels are regularly checked with Continuous Glucose Monitoring (CGM) devices. Drugs like Metformin are routinely used for Type 2 diabetes in order to improve insulin sensitivity and decrease the liver's production of glucose. Sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, Thiazolidinediones (TZDs), and GLP-1 receptor agonists are other oral medications that either raise insulin production or enhance the body's sensitivity to insulin. Insulin therapy may also be necessary for some persons with Type 2 diabetes.⁶⁰ Treatment for gestational diabetes usually begins with food and exercise, although insulin or occasionally oral drugs like Metformin may be used if blood sugar levels don't go down. Regular blood sugar readings are crucial for managing diabetes in addition to medicine, and patients are routinely counselled to maintain their weight, eat a balanced diet, and exercise frequently.⁶¹ To assist avoid issues, doctors may occasionally prescribe extra drugs, such as statins for cholesterol control or ACE inhibitors for high blood pressure. Every treatment plan is unique, taking into account each patient's unique requirements and current state of health.⁶²

INSULIN:

An essential hormone that controls blood sugar (glucose) levels is insulin. The pancreas, more notably the beta cells in the islets of Langerhans, are responsible for manufacturing it. Insulin's main function is to aid in the liver's storage of extra glucose as glycogen and to assist cells in absorbing glucose from the bloodstream for energy. It also aids in controlling the metabolism of proteins and fats.⁶³

TYPE OF INSULIN:

Insulin comes in a variety of forms, each with a unique start, peak, and duration of action. Because of these variations, they can be used in various treatment plans based on the needs of the patient.⁶⁴

1. Rapid-Acting Insulin: This kind lasts for three to five hours, peaks in one to two hours, and starts to operate within fifteen minutes. It is often taken immediately before or immediately after meals to avoid blood sugar spikes. Examples include insulin aspart (NovoLog) and insulin lispro (Humalog).⁶⁵

2. Short-acting insulin, also referred to as regular insulin, starts working within 30 minutes, peaks two to three hours later, and lasts for six to eight hours. It is frequently used to regulate blood sugar levels before to meals. One example is regular insulin (Humulin R).⁶⁶

3. Intermediate-Acting Insulin: This type of insulin has a half-life of 12–18 hours, begins to act in 2-4 hours, and peaks in 4–12 hours. It aids in controlling blood sugar levels during the day and at night. One example is NPH insulin (Humulin N).⁶⁷

4. Long-Acting Insulin: This type of insulin acts gradually and maintains a constant, baseline level of insulin all day and night without experiencing any notable surges. It may last for twenty to twenty-four hours. Insulin glargine (Lantus) and insulin detemir (Levemir) are two examples.⁶⁸

5. Ultra-Long-Acting Insulin: Compared to long-acting insulin, ultra-long-acting insulin can last up to 36 hours before losing its effects. Tresiba, or insulin degludec, is one example.⁶⁹

STRUCTURE OF INSULIN:

The two polypeptide chains that make up the peptide hormone insulin are the A-chain and the B-chain, which are connected by disulphide bonds. In the pancreas, beta cells in the islets of Langerhans create it. 70 Prior to the development of synthetic forms, animal-derived insulin was used because of the great degree of structural conservation of insulin and the few differences in amino acid sequences between humans and other animals, such as pigs or cows. A-chain: The A-chain consists of 21 amino acids and is responsible for the hormone's biological activity. B-chain: The B-chain is longer, consisting of 30 amino acids, and it plays a crucial role in insulin's ability to interact with its receptor on target cells. The correct conformation and function of insulin depend on the presence of two disulfide bonds connecting the A-chain and the B-chain.⁷¹ Proinsulin is a single-chain molecule that serves as a precursor to insulin. After that, the mature, active version of insulin is produced when proinsulin is broken down to remove a linking peptide (C-peptide). Because of its structure, insulin may attach to insulin receptors on cell membranes, which makes it easier for cells to absorb glucose and controls blood sugar levels. Blood glucose levels closely control the synthesis and release of insulin, and disorders such as diabetes mellitus can result from any interference with insulin function or production.⁷²

Diagram: 1 Structure of Insulin

INSULIN ADMINISTRATION:

Insulin is typically administered through subcutaneous injections, as the digestive system would break it down before it could enter the bloodstream if taken orally. Insulin can be delivered

Syringes: The old-fashioned way to inject insulin.

Insulin Pens: Easy injection and dosage with these handy, pre-filled pens.

Insulin pumps are machines that continuously administer insulin via a tiny tube that is placed beneath the skin.

Insulin Inhalers: Some forms of rapid-acting insulin can be inhaled, though this method is less common.⁷³

ROLE OF INSULIN IN DIABETES:

For individuals with Type 1 diabetes, the pancreas does not produce insulin, so they need to take insulin regularly to manage their blood sugar levels.⁷⁴ In Type 2 diabetes, the body may grow resistant to insulin, or the pancreas may not generate enough insulin. As the condition advances, persons with Type 2 diabetes may need insulin therapy, particularly if oral drugs and lifestyle adjustments are no longer sufficient to control blood sugar levels.⁷⁵

CONCLUSION:

To sum up, diabetes mellitus is a frequent and deadly long-term illness that has a big influence on the body's capacity to control blood sugar levels. Type 2 diabetes, a more widespread variant in which the body develops resistance to insulin, and Type 1 diabetes, an autoimmune condition in which the pancreas produces little or no insulin, are its key components. Another type of diabetes that may boost the possibility of having Type 2 diabetes later in life is gestational diabetes, which occurs during pregnancy. The prevalence of diabetes, particularly Type 2, is on the rise worldwide, underscoring the pressing need for governmental and individual health initiatives. Managing Diabetes Mellitus involves a multifaceted approach, combining lifestyle modifications such as proper nutrition, physical activity, and weight management with the regular monitoring of blood sugar levels. In many circumstances, medication or insulin therapy is necessary to maintain healthy blood glucose levels. Effective care is crucial to preventing severe problems such as heart disease, kidney failure, neuropathy, and visual loss, which can drastically diminish quality of life and raise the risk of premature death. Education and awareness have a crucial role in reducing the prevalence of diabetes and improving outcomes for those diagnosed with the condition. Early detection and persistent management can help persons lead healthier lives, minimizing the risk of complications and improving their long-term prognosis. Furthermore, preventive efforts such as promoting healthier lives and boosting access to medical care are vital for fighting the growing diabetes epidemic globally.

RESULT:

Chronic diabetes mellitus reduces the body's capacity to control blood sugar levels. Type 1 is marked by the body's inability to manufacture insulin, while Type 2 is characterised by the body's resistance to insulin. A balanced diet, regular blood sugar readings, exercise, and, if necessary, medication or insulin therapy are all necessary for effective control. In order to avoid complications including heart disease, kidney failure, and nerve damage, early detection and therapies are crucial. People with diabetes can live healthy lives and minimize their risk of significant health problems with the correct care and lifestyle modifications.

REFERENCE:

1. Baxtiyarovich AR, Hamzayevna NS. The Effects And Management Of Diabetes Mellitus. Yangi O Zbekiston, Yangi Tadqiqotlar Jurnali. 2025; 2(1): 90-2.

2. Qaid MM, Abdelrahman MM. Role of insulin and other related hormones in energy metabolism—A review. Cogent Food & Agriculture. 2016; 2(1):1267691.

3. Balaji R, Duraisamy R, Kumar MP. Complications of diabetes mellitus: A review. Drug Invention Today. 2019; 12(1).

4. Gogan A, Potre O, Avram VF, Andor M, Caruntu F, Timar B. Cardiac Autonomic Neuropathy in Diabetes Mellitus: Pathogenesis, Epidemiology, Diagnosis and Clinical Implications: A Narrative Review. Journal of Clinical Medicine. 2025; 14(3): 671.

5. Sayed Ahmed HA, Mohamed SF, Joudeh AI, Elotla SF, Mostafa M, Shah J, Fouad AM, Abdelazim SA. Combined symptoms of diabetes distress, depression, and anxiety and their association with glycemic control in primary care patients with type 2 diabetes in Egypt. Diabetology International. 2025 :1-3

6. Chiang JL, Maahs DM, Garvey KC, Hood KK, Laffel LM, Weinzimer SA, Wolfsdorf JI, Schatz D. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care. 2018; 41(9):2026.

7. Alsheikh, H., Hazzazi, A., Alannaz, A., & Abualkhair, L. Association of Oral Health and Diabetes. Saudi J Oral Dent Res. 2025; 10(4): 205-209.

8. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark Å. Type 1 diabetes mellitus. Nature reviews Disease primers. 2017; 3(1):1-7.

9. Haller MJ, Atkinson MA, Schatz D. Type 1 diabetes mellitus: etiology, presentation, and management. Pediatric Clinics. 2005; 52(6): 1553-78.

10. Aathira R, Jain V. Advances in management of type 1 diabetes mellitus. World Journal of Diabetes. 2014; 5(5): 689.

11. Reinehr T, Wabitsch M. Type 2 diabetes mellitus in children and adolescents. Prevention of type 2 diabetes. 2005:21-40.

12. Ozougwu JC, Obimba KC, Belonwu CD, Unakalamba CB. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 2013; 4(4): 46-57.

13. Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabetic Medicine. 1994; 11(3): 253-61.

14. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994; 43(8): 1066-85.

15. Tahrani AA, Bailey CJ, Del Prato S, Barnett AH. Management of type 2 diabetes: new and future developments in treatment. The Lancet. 2011; 378(9786): 182-97.

16. Buchanan TA, Xiang AH. Gestational diabetes mellitus. The Journal of Clinical Investigation. 2005; 115(3): 485-91.

17. Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care. 2007; 30(4): 878-83.

18. O’Sullivan JB. The Boston gestational diabetes studies: review and perspectives. Carbohydrate Metabolism in Pregnancy and the Newborn· IV. 1989: 287-94.

19. Cheung NW. The management of gestational diabetes. Vascular Health and Risk Management. 2009:153-64.

20. Urakami T. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2019: 1047-56.

21. Rafique I, Mir A, Saqib MA, Naeem M, Marchand L, Polychronakos C. Causal variants in Maturity Onset Diabetes of the Young (MODY)–A systematic review. BMC Endocrine Disorders. 2021; 21: 1-6.

22. Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). Bmj. 2011; 343.

23. Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia. 2005; 48: 2206-12.

24. Davies H, Brophy S, Fielding A, Bingley P, Chandler M, Hilldrup I, Brooks C, Williams R. Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization. Diabetic Medicine. 2008; 25(11): 1354-7.

25. Pieralice S, Pozzilli P. Latent autoimmune diabetes in adults: a review on clinical implications and management. Diabetes & Metabolism Journal. 2018; 42(6): 451.

26. Irvine WJ. Classification of idiopathic diabetes. The Lancet. 1977; 309(8012): 638-42.

27. Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T. Diabetes Mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology. 2021; 2(2):36-50.

28. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D’Agostino RB, Wilson PW, Savage PJ. Trends in cardiovascular complications of diabetes. JAMA. 2004; 292(20): 2495-9.

29. John S. Complication in diabetic nephropathy. Diabetes & Metabolic Syndrome: Clinical Research and Reviews. 2016; 10(4): 247-9.

30. Ahamed MM, Banji O. A review on diabetic neuropathy and nephropathy. International Journal of Pharmaceutical Sciences and Research. 2012; 3(2):300.

31. Nentwich MM, Ulbig MW. Diabetic retinopathy-ocular complications of diabetes mellitus. World Journal of Diabetes. 2015; 6(3): 489.

32. Dryden M, Baguneid M, Eckmann C, Corman S, Stephens J, Solem C, Li J, Charbonneau C, Baillon-Plot N, Haider S. Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. Clinical Microbiology and Infection. 2015; 21:S27-32.

33. de Macedo GM, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetology and Metabolic Syndrome. 2016; 8: 1-8.

34. Nguyen AT, Akhter R, Garde S, Scott C, Twigg SM, Colagiuri S, Ajwani S, Eberhard J. The association of periodontal disease with the complications of diabetes mellitus. A systematic review. Diabetes Research and Clinical Practice. 2020; 165: 108244.

35. Samocha-Bonet D, Wu B, Ryugo DK. Diabetes mellitus and hearing loss: A review. Ageing Research Reviews. 2021; 71: 101423.

36. Hoban C, Sareen J, Henriksen CA, Kuzyk L, Embil JM, Trepman E. Mental health issues associated with foot complications of diabetes mellitus. Foot and Ankle Surgery. 2015; 21(1): 49-55.

37. Parkman HP, Wilson LA, Farrugia G, Koch KL, Hasler WL, Nguyen LA, Abell TL, Snape W, Clarke J, Kuo B, McCallum RW. Delayed gastric emptying associates with diabetic complications in diabetic patients with symptoms of gastroparesis. Official Journal of the American College of Gastroenterology, ACG. 2019; 114(11): 1778-94.

38. Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual dysfunction: current perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2014:95-105.

39. Malka D, Hammel P, Sauvanet A, Rufat P, O'Toole D, Bardet P, Belghiti J, Bernades P, Ruszniewski P, Lévy P. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology. 2000; 119(5): 1324-32.

40. Bener A, Zirie M, Al-Rikabi A. Genetics, obesity, and environmental risk factors associated with type 2 diabetes. Croatian medical journal. 2005; 46(2).

41. Choi BC, Shi F. Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey. Diabetologia. 2001; 44: 1221-31.

42. Smith Jr SC. Multiple risk factors for cardiovascular disease and diabetes mellitus. The American Journal of Medicine. 2007; 120(3): S3-11.

43. Mayer-Davis EJ, Costacou T. Obesity and sedentary lifestyle: modifiable risk factors for prevention of type 2 diabetes. Current Diabetes Reports. 2001; 1(2):170-6.

44. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. New England Journal of Medicine. 2001; 345(11): 790-7.

45. Game FL, Jones AF. Ethnicity and risk factors for coronary heart disease in diabetes mellitus. Diabetes, Obesity and Metabolism. 2000; 2(2): 91-7.

46. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. New England Journal of Medicine. 2000; 342(13): 905-12.

47. Smith Jr SC. Multiple risk factors for cardiovascular disease and diabetes mellitus. The American Journal of Medicine. 2007; 120(3): S3-11.

48. Cypryk K, Szymczak W, Czupryniak L, Sobczak M, Lewiński A. Gestational diabetes mellitus-an analysis of risk factors. Endokrynologia Polska. 2008; 59(5): 393-7.

49. Legro RS. Diabetes prevalence and risk factors in polycystic ovary syndrome. Obstetrics and Gynecology Clinics of North America. 2001; 28(1): 99-109.

50. Chang SA. Smoking and type 2 diabetes mellitus. Diabetes and Metabolism Journal. 2012; 36(6):399.

51. Robinson DJ, Coons M, Haensel H, Vallis M, Yale JF, Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes and mental health. Canadian Journal of Diabetes.2018;42:S130-41.

52. Clark Jr CM, Lee DA. Prevention and treatment of the complications of diabetes mellitus. New England Journal of Medicine. 1995; 332(18): 1210-7.

53. Walker KZ, O’Dea K, Gomez M, Girgis S, Colagiuri R. Diet and exercise in the prevention of diabetes. Journal of Human Nutrition and Dietetics. 2010; 23(4): 344-52.

54. Gill JM, Cooper AR. Physical activity and prevention of type 2 diabetes mellitus. Sports Medicine. 2008; 38: 807-24.

55. Morisset AS, St‐Yves A, Veillette J, Weisnagel SJ, Tchernof A, Robitaille J. Prevention of gestational diabetes mellitus: a review of studies on weight management. Diabetes/ Metabolism Research and Reviews. 2010; 26(1):17-25.

56. Tibbs TL, Haire-Joshu D. Avoiding high-risk behaviors: smoking prevention and cessation in diabetes care. Diabetes Spectrum. 2002; 15(3): 164-9.

57. Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Annals of Internal Medicine. 2004; 140(3): 211-9.

58. Hamasaki H, Yanai H. Periodic health checkups reduce the risk of hospitalization in patients with type 2 diabetes. Frontiers in Clinical Diabetes and Healthcare. 2023; 4: 1087303.

59. Suman S, Saurabh S. Type 1 Diabetes Prevention and Treatment Utilizing Gene and Cell Replacement Therapy. Therapy. 2025; 6(1): 99-111.

60. Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Annals of Internal Medicine. 2016; 164(11): 740-51.

61. Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, Horton ES, Castorino K, Tate DF. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016; 39(11): 2065.

62. Athyros VG, Mikhailidis DP, Papageorgiou AA, Bouloukos VI, Pehlivanidis AN, Symeonidis AN, Elisaf M. Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease. Journal of Human Hypertension. 2004; 18(11): 781-8.

63. Regina I, Tong F. Overview of insulin: more than a hormone for controlling glucose level. Biomed Eng Commun. 2025; 4(2): 10.

64. Ahmad K. Insulin sources and types: a review of insulin in terms of its mode on diabetes mellitus. Journal of Traditional Chinese Medicine. 2014; 34(2): 234-7.

65. Rys P, Pankiewicz O, Łach K, Kwaskowski A, Skrzekowska-Baran I, Malecki MT. Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review. Diabetes and Metabolism. 2011; 37(3): 190-200.

66. Mannucci E, Monami M, Marchionni N. Short‐acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta‐analysis. Diabetes, Obesity and Metabolism.2009;11(1):53-9.

67. Tricco AC, Ashoor HM, Antony J, Beyene J, Veroniki AA, Isaranuwatchai W, Harrington A, Wilson C, Tsouros S, Soobiah C, Catherine HY. Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis. BMJ. 2014; 349.

68. Rosskamp RH, Park G. Long-acting insulin analogs. Diabetes Care. 1999; 22: B109.

69. Semlitsch T, Engler J, Siebenhofer A, Jeitler K, Berghold A, Horvath K. (Ultra‐) long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2020; 11.

70. Dağaşan S, Erbaş O. Insulin structure, function and diabetes models in animals. Journal of Experimental and Basic Medical Sciences. 2020; 1(3): 96-101.

71. Mann E, Sunni M, Bellin MD. Secretion of insulin in response to diet and hormones. Pancreapedia: The Exocrine Pancreas Knowledge Base. 2020.

72. Steiner DF, Clark JL, Nolan C, Rubenstein AH, Margoliash E, Aten B, Oyer PE. Proinsulin and the biosynthesis of insulin. InRecent progress in hormone research. Proceedings of the 1968 Laurentian Hormone Conference. 1969; 25: 207-282.

73. Panchal A, Shah V, Upadhyay UM. Insulin drug delivery systems: a review. Int. J. Res. Pharm. Sci. 2011; 2: 484-92.

74. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988; 37(12): 1595-607.

75. Rahman MS, Hossain KS, Das S, Kundu S, Adegoke EO, Rahman MA, Hannan MA, Uddin MJ, Pang MG. Role of insulin in health and disease: an update. International Journal of Molecular Sciences. 202; 22(12): 6403.

Received on 20.03.2025 Revised on 15.04.2025

Accepted on 10.05.2025 Published on 15.04.2026

Available online from April 18, 2026

Asian J. Pharm. Res. 2026; 16(2):179-186.

DOI: 10.52711/2231-5691.2026.00027

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.